| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.920443 |
| 003 | CaOODSP |
| 005 | 20230529150717 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 230227t20232023onc ob f000 0 eng d |
| 020 | |a9780660478159|q(report) |
| 020 | |a9780660478166|q(summary) |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP5-157/1-2023E-PDF |
| 086 | 1 |aHP5-157/2-2023E-PDF |
| 245 | 00|aGuidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19. |
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023. |
| 264 | 4|c©2023 |
| 300 | |a1 online resource (17 pages) + |e1 summary (5 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCover title. |
| 500 | |a"Published: March 3, 2023." |
| 500 | |a"On cover: Protecting and empowering Canadians to improve their health." |
| 500 | |aAt head of title: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). |
| 500 | |a"Summary of National Advisory Committee on Immunization (NACI) statement of March 3, 2023." |
| 500 | |aIssued also in French under title: Directives sur une dose de rappel supplémentaire du vaccin contre la COVID-19 au printemps 2023 pour les personnes présentant un risque élevé de maladie sévère due à la COVID-19. |
| 504 | |aIncludes bibliographical references (pages 13-17). |
| 520 | |a"On January 20, 2023, NACI published Guidance on COVID-19 vaccine booster doses: initial considerations for 2023. This guidance consolidated and reinforced previously established booster dose recommendations and extended the fall booster program for those who had not yet received a 2022 recommended booster dose into 2023"--Background, page 4. |
| 650 | 0|aCOVID-19 (Disease)|xVaccination|zCanada. |
| 650 | 0|aCOVID-19 (Disease)|xVaccination|xGovernment policy|zCanada. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
| 775 | 08|tDirectives sur une dose de rappel supplémentaire du vaccin contre la COVID-19 au printemps 2023 pour les personnes présentant un risque élevé de maladie sévère due à la COVID-19.|w(CaOODSP)9.920444 |
| 856 | 40|qPDF|s624 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-157-1-2023-eng.pdf|zGuidance |
| 856 | 40|qPDF|s414 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-157-2-2023-eng.pdf|zSummary |
| 986 | |a220791 |
| 986 | |a220793 |